LeMaitre Vascular (LMAT) Earnings Date, Estimates & Call Transcripts $82.97 -0.31 (-0.37%) As of 01:27 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LeMaitre Vascular Earnings Summary LeMaitre Vascular released Q1 2025 earnings on May 1, 2025, reporting an EPS of $0.48, which missed the consensus estimate of $0.50 by $0.02. Quarterly revenue rose 12.0% year-over-year to $59.87 million, above analyst estimates of $57.61 million. With a trailing EPS of $1.98 and a P/E Ratio of 45.34, LeMaitre Vascular's earnings are expected to grow 11.86% next year, from $1.94 to $2.17 per share. Latest Q1 Earnings DateMay. 1EstimatedConsensus EPS (May. 1) $0.50 Actual EPS (May. 1) $0.48 Missed By -$0.02 Actual Revenue (May. 1) $59.87MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)Powered by Get LeMaitre Vascular Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LeMaitre Vascular and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLMAT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LMAT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. LeMaitre Vascular Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252$0.50$0.54$0.52$58.1 M0.480 - 0.530$56.7 M - $58.7 MQ2 20252$0.51$0.53$0.52$60.8 M0.550 - 0.590$61.5 M - $63.5 MQ3 20252$0.51$0.57$0.54Q4 20252$0.53$0.60$0.57 FY 2025 8 $2.05 $2.24 $2.15 Q1 20261$0.60$0.60$0.60Q2 20261$0.69$0.69$0.69Q3 20261$0.65$0.65$0.65Q4 20261$0.68$0.68$0.68 LeMaitre Vascular Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025$0.50$0.48 -$0.02$0.48$57.61M$59.87M2/27/2025Q4 2024$0.49$0.49-$0.49$55.99M$55.81M10/31/2024Q3 2024$0.44$0.49+$0.05$0.49$53.50M$54.82M8/1/2024Q2 2024$0.47$0.52+$0.05$0.52$54.98M$55.85M5/2/2024Q1 2024$0.39$0.44+$0.05$0.44$51.50M$53.48M2/27/2024Q4 2023$0.36$0.38+$0.02$0.38$49.01M$48.90M11/1/2023Q3 2023$0.31$0.33+$0.02$0.33$47.58M$47.40M8/1/2023Q2 2023$0.32$0.37+$0.05$0.38$48.29M$50.12M LeMaitre Vascular Earnings - Frequently Asked Questions When did LeMaitre Vascular announce their last quarterly earnings? LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earning data on Thursday, May 1, 2025. Learn more on LMAT's earnings history. What guidance has LeMaitre Vascular issued on next quarter's earnings? LeMaitre Vascular updated its FY 2025 earnings guidance on Thursday, May, 1st. The company provided EPS guidance of 2.070-2.240 for the period, compared to the consensus EPS estimate of 2.230. The company issued revenue guidance of $242.0 million-$249.0 million, compared to the consensus revenue estimate of $239.3 million. Did LeMaitre Vascular beat their earnings estimates last quarter? In the previous quarter, LeMaitre Vascular (NASDAQ:LMAT) missed the analysts' consensus estimate of $0.50 by $0.02 with a reported earnings per share (EPS) of $0.48. Learn more on analysts' earnings estimate vs. LMAT's actual earnings. How can I listen to LeMaitre Vascular's earnings conference call? The conference call for LeMaitre Vascular's latest earnings report can be listened to online. Listen to Conference Call How can I read LeMaitre Vascular's conference call transcript? The conference call transcript for LeMaitre Vascular's latest earnings report can be read online. Read Transcript How much revenue does LeMaitre Vascular generate each year? LeMaitre Vascular (NASDAQ:LMAT) has a recorded annual revenue of $226.26 million. How much profit does LeMaitre Vascular generate each year? LeMaitre Vascular (NASDAQ:LMAT) has a recorded net income of $30.10 million. LMAT has generated $1.98 earnings per share over the last four quarters. What is LeMaitre Vascular's price-to-earnings ratio? LeMaitre Vascular (NASDAQ:LMAT) has a trailing price-to-earnings ratio of 45.51 and a forward price-to-earnings ratio of 42.93. The price/earnings-to-growth ratio is 2.22. What is LeMaitre Vascular's EPS forecast for next year? LeMaitre Vascular's earnings are expected to grow from $1.94 per share to $2.17 per share in the next year, which is a 11.86% increase. More Earnings Resources from MarketBeat Related Companies STVN Earnings GKOS Earnings INSP Earnings NARI Earnings IRTC Earnings BLCO Earnings SLNO Earnings TMDX Earnings PRCT Earnings NVST Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery? This page (NASDAQ:LMAT) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersAI Boom Takes a Shocking Turn…The AI “Gold Rush” is Here… History's repeating itself — but this time, the shovels are digital. Crypto 101 Media | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBITCOIN Liquidity pools are the backbone of crypto—and right now, they’re exploding with activity. By providing liqui...Awesomely, LLC | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LMAT Stock Free LMAT Stock Alerts